|
⚲
|
| Keyboard |
| Lang James Paul
✚
|
|
|---|---|
| CIK # | 0001703090 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001703090] | |
| 4 | [0001703090] | |
| 5 | [0001703090] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| OptimizeRx Corp | |
| Lang James Paul | |
| Halozyme Therapeutics Inc | |
| Biovie Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Biovie Inc BIVI
Stock Option (right to buy) · derivative
|
2026-01-05 | Grant | 330,500 | $0.00 | |
|
Biovie Inc BIVI
Stock Option (right to buy) · derivative
|
2026-01-05 | Grant | 90,000 | $0.00 | |
|
Halozyme Therapeutics Inc HALO
Option to Purchase Common Stock · derivative
|
2026-01-02 | Grant | 1,342 | $0.00 | |
|
Halozyme Therapeutics Inc HALO
Restricted Stock Units
|
2026-01-02 | Grant | 889 | $0.00 | |
|
OptimizeRx Corp OPRX
Common Stock
|
2025-06-11 | Grant | 9,868 | $0.00 | |
|
OptimizeRx Corp OPRX
Common Stock
|
2025-03-14 | Buy | 321,408 | $7.60 | 2,442,701 |
|
Biovie Inc BIVI
Stock Option (right to buy) · derivative
|
2024-12-20 | Grant | 22,690 | $0.00 | |
|
Biovie Inc BIVI
Stock Option (right to buy) · derivative
|
2024-11-20 | Grant | 61,600 | $0.00 | |
|
OptimizeRx Corp OPRX
Common Stock
|
2024-06-07 | Grant | 13,286 | $0.00 | |
|
OptimizeRx Corp OPRX
Common Stock
|
2024-06-05 | Option exercise | 10,061 | $0.00 | |
|
OptimizeRx Corp OPRX
Restricted Stock Units · derivative
|
2024-06-05 | Option exercise | 10,061 | $0.00 | |
|
Biovie Inc BIVI
Stock Option (right to buy) · derivative
|
2023-11-09 | Grant | 93,500 | $0.00 | |
|
OptimizeRx Corp OPRX
Restricted Stock Units · derivative
|
2023-06-07 | Option exercise | 4,637 | $0.00 | |
|
OptimizeRx Corp OPRX
Common Stock
|
2023-06-07 | Option exercise | 4,637 | $0.00 | |
|
OptimizeRx Corp OPRX
Restricted Stock Units · derivative
|
2023-06-07 | Grant | 10,061 | $0.00 | |
|
OptimizeRx Corp OPRX
Common Stock
|
2023-03-30 | Option exercise | 657 | $0.00 | |
|
OptimizeRx Corp OPRX
Restricted Stock Units · derivative
|
2023-03-30 | Option exercise | 657 | $0.00 | |
|
OptimizeRx Corp OPRX
Common Stock
|
2022-12-30 | Option exercise | 409 | $0.00 | |
|
OptimizeRx Corp OPRX
Restricted Stock Units · derivative
|
2022-12-30 | Option exercise | 409 | $0.00 | |
|
Biovie Inc BIVI
COMMON STOCK
|
2022-11-23 | Grant | 43,578 | $0.00 | |
| showing 20 of 57 most recent transactions | |||||